Patent application number | Description | Published |
20090305343 | Method For Expressing Polypeptides In Eukaryotic Cells Using Alternative Splicing - This invention relates to an expression cassette for expressing polypeptides in eukaryotic cells using alternative splicing. The expression cassette comprises in 5′ to 3′ downstream direction: a promoter; a sequence transcribed in a 5′ untranslated region (5′UTR); a donor splice site; an intron; a first acceptor splice site; a first cistron encoding a first polypeptide; a second acceptor splice site; a second cistron encoding a second polypeptide; an internal ribosome entry site (IRES) operably linked to a selection marker; and a sequence transcribed in a 3″ untranslated region (3′UTR) including a polyadenylation signal, wherein the polyadenylation signal is unique. | 12-10-2009 |
20100273669 | METHOD FOR SELECTING A PEPTIDE OR POLYPEPTIDE WHICH BINDS TO A TARGET - A method for selecting a peptide or polypeptide which binds to a target is provided. The method is based on protein splicing and phage display. | 10-28-2010 |
20120009188 | OPTIMIZED FC VARIANTS - A variant of a parent polypeptide including an Fc region, which variant exhibits increased binding to FcRn as compared to the parent polypeptide and includes at least one amino acid modification in the Fc region. | 01-12-2012 |
20140141019 | ANTIBODIES AGAINST HER3 - The invention relates to antibodies against HER3 and their use in the treatment of cancer. | 05-22-2014 |
20140378663 | FC VARIANTS WITH REDUCED EFFECTOR FUNCTIONS - A method for producing a variant of a parent polypeptide including a Fc region, which variant exhibits reduced binding to the protein C1q and to at least one receptor Fcgγ R as compared to the parent polypeptide. | 12-25-2014 |
Patent application number | Description | Published |
20090017147 | Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract - The invention provides a cosmetic or dermopharmaceutic composition containing an | 01-15-2009 |
20110002865 | MOISTURIZING COSMETIC COMPOSITION COMPRISING A COMBINATION OF HOMARINE AND ERYTHRITOL - The subject matter of the present invention is a cosmetic or dermopharmaceutic composition comprising a combination of homarine and erythritol as well as a non-therapeutic treatment method of the skin to improve cutaneous hydration, to prevent and/or treat cutaneous dryness signs, to restore and/or protect the cutaneous barrier function, to protect cells of the skin and/or of the scalp from osmotic shocks, for example from UV induced osmotic shocks. | 01-06-2011 |
20110033507 | Polypeptides KXK and Their Use - The invention concerns polypeptides of the general formula (I): A-(Xaa) | 02-10-2011 |
20110092821 | DEVICE FOR MEASURING THE MECHANICAL PROPERTIES OF THE SKIN WITHOUT CONTACT WITH THE MEASUREMENT ZONE - The invention relates to a device for measuring the mechanical properties of the skin which is free from all parameters interfering with measurement. The device comprises: a) a pneumatic assembly ( | 04-21-2011 |
20120028916 | COSMETIC COMPOSITIONS COMPRISING ORIDONIN AND NEW COSMETIC USES - The present invention related to cosmetic compositions comprising oridonin and new cosmetic uses. Oridonin is used for fighting the signs of cutaneous aging and for slimming. A composition comprising a combination of oridonin and darutigenol or a derivative thereof, in particular darutoside, is disclosed together with the cosmetic use of such composition. | 02-02-2012 |
20120076842 | COSMETIC USE OF TYR-ARG DIPEPTIDE TO COMBAT CUTANEOUS SAGGING - The present invention concerns a new cosmetic use of Tyr-Arg dipeptide to stimulate molecules of the extracellular matrix in order to prevent and treat cutaneaous sagging, in particular due to natural gravity. | 03-29-2012 |
20130058878 | Cosmetic Use Of Geranylgeranyl-2-Propanol - Geranylgeranyl-2-propanol compound (GGP) having the following formula (I) is proposed for use according to the present invention as a cosmetic active compound for the prevention and treatment of aging of skin and its appendages. The GGP has a protective action against oxidative stress and free radical, on telomeres and on mitochondria and its activity. In particular, GGP can be used for the treatment of wrinkles, fine lines and visible discontinuities of skin, for the treatment pigmentation disorders. | 03-07-2013 |